Clinical Trials Browser

Phase 3 × Interventional × 64Cu-DOTATATE × Clear all

NCT03673943 2022-12-22

Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE

Phase 3 Completed

63 enrolled 8 charts

Neuroendocrine Tumors